Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

BACKGROUND: Durvalumab as maintenance treatment after platinum-based concurrent chemoradiotherapy (cCRT) has become the standard of care in inoperable stage III non-small cell lung cancer (NSCLC). In this nationwide survey, we solicited members of the German Radiation Oncology Society to review the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Transl Lung Cancer Res
Главные авторы: Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Roengvoraphoj, Olarn, Belka, Claus, Manapov, Farkhad
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225149/
https://ncbi.nlm.nih.gov/pubmed/32420068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.25
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы